| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 31-Dec-08 | | Total Revenue | 16,030 | 14,598 | 16,653 | 22,875 | | Cost of Revenue | 13,155 | 12,923 | 15,571 | 25,212 | | | Gross Profit | 2,875 | 1,675 | 1,082 | (2,337) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,776 | 4,061 | 4,157 | 5,570 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (901) | (2,386) | (3,075) | (7,907) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (901) | (2,386) | (3,075) | (7,907) | | Interest Expense | 78 | 78 | 77 | 98 | | Income Before Tax | (979) | (2,464) | (3,152) | (8,005) | | Income Tax Expense |
-
|
-
|
-
| 6 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (979) | (2,464) | (3,152) | (8,011) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (979) | (2,464) | (3,152) | (8,011) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($979) | ($2,464) | ($3,152) | ($8,011) |
|
0.26% Nasdaq 
0.02 (0.87%) 
Income Statement
